Cargando…

Evaluation of afoxolaner chewables to control flea populations in naturally infested dogs in private residences in Tampa FL, USA

BACKGROUND: A study was conducted to evaluate the effectiveness of afoxolaner chewables to control flea populations in naturally infested dogs in private residences in Tampa FL, USA. Evaluations of on-animal and premises flea burdens, flea sex structure and fed-unfed premises flea populations were c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dryden, Michael W., Smith, Vicki, Chwala, Monica, Jones, Emery, Crevoiserat, Lisa, McGrady, Jennifer C., Foley, Kaitlin M., Patton, Paula R., Hawkins, Anthony, Carithers, Doug
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445572/ https://www.ncbi.nlm.nih.gov/pubmed/26003175 http://dx.doi.org/10.1186/s13071-015-0897-z

Ejemplares similares

Evaluation of indoxacarb and fipronil (s)-methoprene topical spot-on formulations to control flea populations in naturally infested dogs and cats in private residences in Tampa FL. USA
por: Dryden, Michael W, et al.
Publicado: (2013)

Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA
por: Dryden, Michael W., et al.
Publicado: (2016)

Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs
por: Carithers, Doug, et al.
Publicado: (2016)

Monthly administrations of milbemycin oxime plus afoxolaner chewable tablets to prevent Angiostrongylus vasorum infection in dogs
por: Lebon, Wilfried, et al.
Publicado: (2016)

Enhanced Disease Surveillance during the 2012 Republican National Convention, Tampa, FL
por: Atrubin, David, et al.
Publicado: (2013)

Treatment of canine sarcoptic mange with afoxolaner (NexGard(®)) and afoxolaner plus milbemycin oxime (NexGard Spectra(®)) chewable tablets: efficacy under field conditions in Portugal and Germany
por: Hampel, Verena, et al.
Publicado: (2018)

Insecticide/acaricide resistance in fleas and ticks infesting dogs and cats
por: Coles, Tad B, et al.
Publicado: (2014)

Afoxolaner against fleas: immediate efficacy and resultant mortality after short exposure on dogs
por: Beugnet, Frédéric, et al.
Publicado: (2014)

Evaluation of sarolaner and spinosad oral treatments to eliminate fleas, reduce dermatologic lesions and minimize pruritus in naturally infested dogs in west Central Florida, USA
por: Dryden, Michael W., et al.
Publicado: (2017)

Efficacy of milbemycin oxime/afoxolaner chewable tablets (NEXGARD SPECTRA(®)) against Capillaria aerophila and Capillaria boehmi in naturally infected dogs
por: Di Cesare, Angela, et al.
Publicado: (2021)

Efficacy of imidacloprid + moxidectin and selamectin topical solutions against the KS1 Ctenocephalides felis flea strain infesting cats
por: Dryden, Michael W, et al.
Publicado: (2011)

Efficacy of selamectin, spinosad, and spinosad/milbemycin oxime against the KS1 Ctenocephalides felis flea strain infesting dogs
por: Dryden, Michael W, et al.
Publicado: (2013)

Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei
por: Beugnet, Frédéric, et al.
Publicado: (2016)

Implementing a Voluntary, Nonregulatory Approach to Nitrogen Management in Tampa Bay, FL: A Public/Private Partnership
por: Greening, Holly, et al.
Publicado: (2001)

Efficacy of indoxacarb applied to cats against the adult cat flea, Ctenocephalides felis, flea eggs and adult flea emergence
por: Dryden, Michael W, et al.
Publicado: (2013)

Afoxolaner as a Treatment for a Novel Sarcoptes scabiei Infestation in a Juvenile Potbelly Pig
por: Smith, Joe S., et al.
Publicado: (2020)

Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA
por: Kryda, Kristina, et al.
Publicado: (2020)

Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe
por: Becskei, Csilla, et al.
Publicado: (2020)

Speed of flea knockdown of spinosad compared to afoxolaner, and of spinosad through 28 days post-treatment in controlled laboratory studies
por: Snyder, Daniel E., et al.
Publicado: (2015)

Evaluation and comparison of a flumethrin-imidacloprid collar and repeated monthly treatments of fipronil/(s)-methoprene to control flea, Ctenocephalides f. felis, infestations on cats for eight months
por: Dryden, Michael W., et al.
Publicado: (2016)

Efficacy of afoxolaner (NexGard®) against natural infestations with Trichodectes canis in dogs under field conditions
por: Mihalca, Andrei Daniel, et al.
Publicado: (2022)

Development of advantus™(imidacloprid) soft chewable tablets for the treatment of Ctenocephalides felis infestations on dogs
por: Qureshi, Tariq, et al.
Publicado: (2015)

A field trial of spinosad for the treatment and prevention of flea infestation in shepherd dogs living in close proximity to flea-infested sheep
por: Saridomichelakis, Manolis N., et al.
Publicado: (2015)

Tampa Red (1928-1942)
Publicado: (1983)

Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Ixodes scapularis on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Ctenocephalides felis on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Comparative speed of kill of sarolaner (Simparica(™)) and afoxolaner (NexGard(®)) against induced infestations of Amblyomma americanum on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Comparative speed of kill of sarolaner (Simparica(®)) and afoxolaner (NexGard(®)) against induced infestations of Ixodes holocyclus on dogs
por: Packianathan, Raj, et al.
Publicado: (2017)

Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs
por: Kohler-Aanesen, Heike, et al.
Publicado: (2017)

Shaping the future of ICT research: IFIP WG 8. 2 working conference, Tampa, FL, USA, December 13-14, 2012, proceedings
por: Bhattacherjee, Anol, et al.
Publicado: (2012)

In-home assessment of either topical fluralaner or topical selamectin for flea control in naturally infested cats in West Central Florida, USA
por: Dryden, Michael W., et al.
Publicado: (2018)

Efficacy of fluralaner chewable tablets (Bravecto(®)) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogs
por: Petersen, Melissa, et al.
Publicado: (2023)

Cat Flea Infestation in a Hospital: A Case Report
por: Leelavathi, Muthupalaniappen, et al.
Publicado: (2012)

Fleas infesting pets in the era of emerging extra-intestinal nematodes
por: Traversa, Donato
Publicado: (2013)

Flea infestation on small wild mammals in Gharyan, Northwest Libya
por: Belgasm, Waleed Yousuf Mohammed, et al.
Publicado: (2022)

Comparative speed of kill of sarolaner (Simparica™) and afoxolaner (NexGard®) against induced infestations of Rhipicephalus sanguineus s.l. on dogs
por: Six, Robert H., et al.
Publicado: (2016)

DNA computing: 7th international workshop on DNA-based computers, DNA7, Tampa, FL, USA, June 10-13, 2001, revised papers
por: Jonoska, Natasa, et al.
Publicado: (2002)

Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Polish Adaptation of the Modified Tampa Scale of Kinesiophobia for Fatigue (TSK-F) and the Revision of the Tampa Scale in Terms of Pain for Cancer Patients
por: Rozmiarek, Mateusz, et al.
Publicado: (2022)

Evaluation of spinosad for the oral treatment and control of flea infestations on cats in Europe
por: Franc, M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jhdr2un12tc0p51ail3vbogc1j